Literature DB >> 20497262

Use of a novel technology for presenting screening measures to detect mild cognitive impairment in elderly patients.

D W Wright1, F C Goldstein, P Kilgo, J R Brumfield, T Ravichandran, M L Danielson, M Laplaca.   

Abstract

BACKGROUND: Available screening tools for mild cognitive impairment (MCI), often a precursor to Alzheimer's disease, are insensitive or not feasible for administration in a busy primary care setting. Display Enhanced TEsting for Cognitive impairment and Traumatic brain injury (DETECT) addresses these issues by creating an immersive environment for the brief administration of neuropsychological (NP) measures.
OBJECTIVE: The aim of this study was to determine if the DETECT cognitive subtests can identify MCI patients as accurately as standard pen and paper NP tests.
METHODS: Twenty patients with MCI recruited from a memory disorders clinic and 20 age-matched controls were given both a full battery of NP tests (standard NP) and the DETECT screen. Logistic regression models were used to determine whether individual tests were predictive of group membership (MCI or control). Demographic variables including age, race, education and gender were adjusted as covariates. Selection methods were used to identify subset models that exhibited maximum discrimination between MCI patients and controls for both testing methods.
RESULTS: Both the standard NP model (C-index = 0.836) and the DETECT model (C-index = 0.865) showed very good discrimination and were not significantly different (p = 0.7323).
CONCLUSION: The DETECT system shows good agreement with standard NP tests and is capable of identifying elderly patients with cognitive impairment.

Entities:  

Mesh:

Year:  2010        PMID: 20497262     DOI: 10.1111/j.1742-1241.2009.02324.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  4 in total

1.  Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment.

Authors:  Albert M Anderson; Jeffrey L Lennox; Minh L Nguyen; Drenna Waldrop-Valverde; William R Tyor; David W Loring
Journal:  J Neurovirol       Date:  2016-05-31       Impact factor: 2.643

2.  Brief Report: Using the Internet to Identify Persons with Cognitive Impairment for Participation in Clinical Trials.

Authors:  Lindsay F Morra; Jason Brandt
Journal:  Brain Sci       Date:  2017-04-05

3.  Test-Retest Reliability of a Serious Game for Delirium Screening in the Emergency Department.

Authors:  Tiffany Tong; Mark Chignell; Mary C Tierney; Jacques S Lee
Journal:  Front Aging Neurosci       Date:  2016-11-07       Impact factor: 5.750

4.  A Novel Neuropsychological Tool for Immersive Assessment of Concussion and Correlation with Subclinical Head Impacts.

Authors:  Tamara R Espinoza; Kristopher A Hendershot; Brian Liu; Andrea Knezevic; Breanne B Jacobs; Russell K Gore; Kevin M Guskiewicz; Jeffery J Bazarian; Shean E Phelps; David W Wright; Michelle C LaPlaca
Journal:  Neurotrauma Rep       Date:  2021-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.